Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 7Pancreatic Cyst 4Pain 2Colorectal Neoplasms 2Cancer Pain 2Surgical Wound Infection 1Pancreatitis, Chronic 1Pancreatic Mucinous-Cystic Neoplasm 1Pancreatic Intraductal Neoplasms 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasms 1Mucinous Cystic Tumor With Moderate Dysplasia 1Inflammatory Bowel Diseases 1Flushing 1Esophageal Neoplasms 1Diverticulitis 1Cystadenoma, Mucinous 1Cystadenocarcinoma, Mucinous 1Cardiovascular Diseases 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1Alzheimer Disease 1Agnosia 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 130Nivolumab 87atezolizumab 80pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Ethanol × Gastrointestinal × Clear all
NCT04553458 2020-09-17

Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma

Sohag University

Completed
407 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡